Cargando…

Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection

There are limited data on the impact of antenatal antiretroviral regimens (ARV) on pregnancy and infant outcomes in HIV/HBV coinfection. We compared outcomes among 3 antenatal antiretroviral regimens for pregnant women with HIV/HBV. METHODS: The PROMISE study enrolled ARV-naive pregnant women with H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiweewa, Flavia Matovu, Tierney, Camlin, Butler, Kevin, Peters, Marion G., Vhembo, Tichaona, Moodley, Dhayendre, Govender, Vani, Mohtashemi, Neaka, Ship, Hannah, Musoke, Philippa, Dula, Dingase, George, Kathy, Chakhtoura, Nahida, Fowler, Mary G., Currier, Judith S., Bhattacharya, Debika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377493/ https://www.ncbi.nlm.nih.gov/pubmed/35621877 http://dx.doi.org/10.1097/QAI.0000000000003022

Ejemplares similares

Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial
por: Vhembo, Tichaona, et al.
Publicado: (2023)

Micronutrients and nutritional status among children living with HIV with and without severe acute malnutrition: IMPAACT P1092
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2023)

Evaluation of and implications for a novel hepatitis C e-consult direct-to-treatment pilot program
por: Mohtashemi, Neaka Z., et al.
Publicado: (2023)

1234. Analysis of an Automated Letter HCV Screening Program within a Veterans Affairs Health System: Implications for Universal HCV Screening
por: Harjono, Lucas, et al.
Publicado: (2022)

Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High‐risk African Women
por: Kiweewa, Flavia Matovu, et al.
Publicado: (2019)

Reliability of last menstrual period recall, an early ultrasound and a Smartphone App in predicting date of delivery and classification of preterm and post-term births
por: Majola, Linda, et al.
Publicado: (2021)

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

1247. Primary Care Teams in Veterans Health Administration Have High Knowledge of Universal HCV Screening But Favor System-Level Interventions to Close Care Gaps
por: Patel, Arpan, et al.
Publicado: (2022)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda
por: Kiweewa Matovu, Flavia, et al.
Publicado: (2022)

Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial
por: Stranix-Chibanda, Lynda, et al.
Publicado: (2021)

Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy
por: Theron, Gerhard, et al.
Publicado: (2020)

HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
por: Ruta, Simona, et al.
Publicado: (2023)

Community Health Workers Improve HIV Disclosure Among HIV-Affected Sexual Partners in Rural Uganda: A Quasi-Experimental Study
por: Lukyamuzi, Zubair, et al.
Publicado: (2022)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

Unusual presentation of meningococcal meningitis in the elderly and utility of CSF PCR testing
por: Ranson, Elizabeth, et al.
Publicado: (2020)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
por: Mavilia, Marianna G., et al.
Publicado: (2018)

Prevalence of HCV and/or HBV coinfection in Iranian HIV-infected patients
por: Dehghani-Dehej, Farzaneh, et al.
Publicado: (2020)

Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
por: Yang, Shanshan, et al.
Publicado: (2022)

Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
por: Puglia, Monia, et al.
Publicado: (2015)

Analysis of HBV and COVID-19 Coinfection Model with Intervention Strategies
por: Teklu, Shewafera Wondimagegnhu
Publicado: (2023)

Ethical and legal constraints to children’s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2012)

HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood
por: Niculescu, Irina, et al.
Publicado: (2013)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
por: Zhang, Qingrong, et al.
Publicado: (2023)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

1248. Relationship Between ALT and New HBV Biomarkers in HBV/HIV Coinfected Persons Started on Antiviral Therapy
por: Rouster, Susan D, et al.
Publicado: (2022)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Prevalence of HBV and HIV coinfection from an infectious disease hospital in Mumbai
por: Shastri, Jayanthi, et al.
Publicado: (2014)

The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management
por: Konstantinou, Dimitris, et al.
Publicado: (2015)

Hemophagocytic lymphohistiocytosis associated with HBV‐HCV coinfection in adult: Case report
por: Bendari, Mounia, et al.
Publicado: (2021)

HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases
por: Cheng, Zhimeng, et al.
Publicado: (2021)

Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients
por: Schmidbauer, Caroline, et al.
Publicado: (2021)

Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1–Infected Young Adult ‐Women Using Depot Medroxyprogesterone Acetate or Nonhormonal Contraceptives in Uganda
por: Matovu, Flavia Kiweewa, et al.
Publicado: (2020)

PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort
por: Sharp, Colin P., et al.
Publicado: (2017)

Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana
por: Matthews, Philippa C., et al.
Publicado: (2015)

HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018
por: Pérez-Latorre, Leire, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m98kls641sda1l065p2lb23piq